Indication
Leber's Hereditary Optic Neuropathy
2 clinical trials
2 products
Clinical trial
Expanded Access Program for Idebenone in Patients With Leber's Hereditary Optic Neuropathy Who Completed the LEROS StudyStatus:
Product
IdebenoneClinical trial
An Open-label Dose Escalation Study of an Adeno-associated Virus Vector (scAAV2-P1ND4v2) for Gene Therapy of Leber's Hereditary Optic Neuropathy (LHON) Caused by the G11778A Mutation in Mitochondrial DNAStatus: Active (not recruiting), Estimated PCD: 2023-03-31
Product
scAAV2-P1ND4v2